An activatable theranostic for targeted cancer therapy and imaging

Angewandte Chemie - International Edition

Volumn 53, Issue 17, 2014, Pages 4469-4474

  Bhuniya, Sankarprasad ^a   Maiti, Sukhendu ^b   Kim, Eun Joong ^a   Lee, Hyunseung ^a   Sessler, Jonathan L ^c   Hong, Kwan Soo ^a   Kim, Jong Seung ^b  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Korea University   (South Korea)

^c The University of Texas at Austin   (United States)

Author keywords

biotin; cellular imaging; glutathione; SN 38; theranostic

Indexed keywords

BIOLOGICAL MATERIALS; COENZYMES; FLUOROPHORES; TUMORS;

BIOTIN; CELLULAR IMAGING; GLUTATHIONES; SN-38; THERANOSTIC;

DIAGNOSIS;

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; FLUORESCENT DYE; IRINOTECAN; PRODRUG; THIOL DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG SCREENING; HUMAN; MOLECULAR IMAGING; MOUSE; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; TISSUE DISTRIBUTION; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL SURVIVAL; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; MICE; MOLECULAR IMAGING; NEOPLASMS, EXPERIMENTAL; PRODRUGS; SULFHYDRYL COMPOUNDS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84899032171     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201311133     Document Type: Article

References (20)

1. E. S. Andersen, M. Dong, M. M. Nielsen, K. Jahn, R. Subramani, W. Mamdouh, M. M. Golas, B. Sander, H. Stark, C. L. P. Oliveira, J. S. Pedersen, V. Birkedal, F. Besenbacher, K. V. Gothelf, J. Kjems, Nature 2009, 459, 73.
2. J. Decock, N. Obermajer, S. Vozelj, W. Hendrickx, R. Paridaens, J. Kos, Int. J. Biol. Markers 2008, 23, 161.
3. N. Yamazaki, S. Kojima, N. V. Bovin, S. Andre, S. Gabius, H. J. Gabius, Adv. Drug Delivery Rev. 2000, 43, 225.
4. S. H. Lee, J. Y. Kim, J. Ko, J. Y. Lee, J. S. Kim, J. Org. Chem. 2004, 69, 2902
5. Y. H. Lee, M. H. Lee, J. F. Zhang, J. S. Kim, J. Org. Chem. 2010, 75, 7159
6. H. J. Kim, J. S. Kim, Tetrahedron Lett. 2006, 47, 7051
7. J. S. Kim, H. J. Kim, H. M. Kim, S. H. Kim, J. W. Lee, S. K. Kim, B. R. Cho, J. Org. Chem. 2006, 71, 8016
8. K. C. Ko, J.-S. Wu, H. J. Kim, P. S. Kwon, J. W. Kim, R. A. Bartsch, J. Y. Lee, J. S. Kim, Chem. Commun. 2011, 47, 3165.
9. S. Maiti, N. Park, J. H. Han, H. M. Jeon, J. H. Lee, S. Bhuniya, C. Kang, J. S. Kim, J. Am. Chem. Soc. 2013, 135, 4567.
10. R. H. J. Mathijssen, R. J. vanAlphen, J. Verweij, W. J. Loos, K. Nooter, G. Stoter, A. Sparreboom, Clin. Cancer Res. 2001, 7, 2182.
11. B. Gatto, G. Capranico, M. Palumbo, Curr. Pharm. Des. 1999, 5, 195.
12. S. Chen, X. Zhao, J. Chen, J. Chen, L. Kuznetsova, S. S. Wong, I. Ojima, Bioconjugate Chem. 2010, 21, 979.
13. B. C. Dickinson, C. J. Chang, J. Am. Chem. Soc. 2008, 130, 9638.
14. J. A. Cook, H. I. Pass, S. N. Iype, N. Friedman, W. DeGraff, A. Russo, J. B. Mitchell, Cancer Res. 1991, 51, 4287.
15. M. Qi, P. Wang, D. Wu, Drug Dev. Ind. Pharm. 2003, 29, 661.
16. K. D. Brown, D. M. Blakeley, P. Roberts, R. J. Avery, Biochem. J. 1985, 229, 119.
17. D. N. Heo, D. H. Yang, H. J. Moon, J. B. Lee, M. S. Bae, S. C. Lee, W. J. Lee, I. C. Sun, I. K. Kwon, Biomaterials 2012, 33, 856.
18. N. Jiang, N. S. Tan, B. Ho, J. L. Ding, Nat. Immunol. 2007, 8, 1114.
19. J. D. Gregory, J. Am. Chem. Soc. 1955, 77, 3922.
20. J. Tomasina, S. Lheureux, P. Gauduchon, S. Rault, A. Malzert- Fréon, Biomaterials 2013, 34, 1073.